Browsing Tag
Sean McClain
5 posts
Absci goes full throttle on AI drug design with Oracle and AMD in its corner
Absci taps Oracle Cloud and AMD’s Instinct GPUs to fast-track AI-powered drug discovery and antibody design. Find out what this means for biotech’s future.
Absci and AMD collaborate to transform AI-driven drug discovery
Absci Corporation and Advanced Micro Devices, Inc. (AMD) have unveiled a strategic collaboration designed to revolutionise drug discovery…
Absci, PrecisionLife collaborate to develop novel biotherapeutics for chronic diseases
Absci (Nasdaq: ABSI), a generative AI drug creation company, and PrecisionLife, a leader in computational biology, today announced…
Absci collaborates with AstraZeneca for AI-designed oncology antibody
Absci Corporation (Nasdaq: ABSI), a leader in generative AI antibody discovery, announced a groundbreaking collaboration with AstraZeneca, a…
Montauk Renewables announces landfill gas-to-energy project in Irvine, CA
Montauk Renewables, via its subsidiary Bowerman Power LFG, has unveiled plans for the development of a renewable natural…